COVID-19: Oxford-AstraZeneca jab benefits outweigh 'rare incidents of risk', says vaccines minister - as regulator reviews clot cases

The benefits of taking the Oxford-AstraZeneca jab "far outweigh" any "rare incidents of risk", the vaccines minister has said, as the UK's drugs regulator investigates reports of blood clots.